IRIS
MARTORANA, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.685
AS - Asia 1.887
EU - Europa 1.832
SA - Sud America 252
AF - Africa 234
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.894
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.617
SG - Singapore 814
RU - Federazione Russa 702
IT - Italia 630
CN - Cina 473
BR - Brasile 207
KR - Corea 174
VN - Vietnam 144
IN - India 115
CI - Costa d'Avorio 112
IE - Irlanda 88
FI - Finlandia 68
FR - Francia 66
DE - Germania 51
GB - Regno Unito 50
NG - Nigeria 49
NL - Olanda 46
CA - Canada 30
SN - Senegal 29
PL - Polonia 27
MX - Messico 26
IQ - Iraq 24
JP - Giappone 23
AR - Argentina 20
CZ - Repubblica Ceca 19
BJ - Benin 18
BD - Bangladesh 16
BE - Belgio 16
HK - Hong Kong 16
ES - Italia 15
SE - Svezia 13
UA - Ucraina 13
ID - Indonesia 12
UZ - Uzbekistan 12
TR - Turchia 11
PK - Pakistan 10
ZA - Sudafrica 10
LT - Lituania 8
AE - Emirati Arabi Uniti 7
AT - Austria 6
IR - Iran 6
VE - Venezuela 6
CO - Colombia 5
IL - Israele 5
AZ - Azerbaigian 4
KE - Kenya 4
OM - Oman 4
TN - Tunisia 4
AU - Australia 3
BG - Bulgaria 3
CH - Svizzera 3
EC - Ecuador 3
JM - Giamaica 3
PH - Filippine 3
PY - Paraguay 3
SA - Arabia Saudita 3
UY - Uruguay 3
CL - Cile 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EG - Egitto 2
LB - Libano 2
MA - Marocco 2
MN - Mongolia 2
MY - Malesia 2
PE - Perù 2
RO - Romania 2
RS - Serbia 2
AO - Angola 1
BB - Barbados 1
BO - Bolivia 1
CG - Congo 1
CY - Cipro 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GR - Grecia 1
HR - Croazia 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
Totale 6.894
Salva come PNG Salva come JPEG
Città #
Dallas 748
Singapore 552
Santa Clara 356
Moscow 329
Hefei 237
San Jose 223
Ashburn 181
Seoul 173
Catania 140
Chicago 136
Los Angeles 116
Chandler 113
Abidjan 112
Dublin 87
Kochi 80
Beijing 61
Lauterbourg 59
New York 57
Boardman 56
Council Bluffs 53
Ho Chi Minh City 41
Palermo 38
Lappeenranta 37
Hanoi 33
Rome 32
Milan 30
Dakar 29
São Paulo 25
Amsterdam 24
Buffalo 24
Lagos 24
Civitanova Marche 23
Tokyo 23
Warsaw 23
Cambridge 21
Abuja 20
Bari 19
Brno 19
Lawrence 19
Orem 19
Turku 19
Cotonou 18
Munich 18
Brussels 16
Andover 15
Hong Kong 15
Chennai 13
Montreal 13
Brooklyn 12
Helsinki 12
San Giovanni la Punta 12
Poplar 11
Atlanta 10
Manchester 10
Stockholm 10
Tashkent 10
Wilmington 10
Da Nang 9
Denver 9
Des Moines 9
Johannesburg 9
London 9
Naples 9
Phoenix 9
Baghdad 8
Bremen 8
Charlotte 8
Cosenza 8
Messina 8
Mexico City 8
Santa Venerina 8
Seattle 8
Columbus 7
Florence 7
Frankfurt am Main 7
Grafing 7
Grammichele 7
Houston 7
San Francisco 7
The Dalles 7
Aci Catena 6
Haiphong 6
Querétaro 6
Tehran 6
Toronto 6
Ankara 5
Jacksonville 5
Port Harcourt 5
Belo Horizonte 4
Dong Ket 4
Genoa 4
Jakarta 4
Mascalucia 4
Mumbai 4
Palagiano 4
Paternò 4
Pisa 4
Pune 4
Ribeirão Preto 4
Rosario 4
Totale 4.892
Salva come PNG Salva come JPEG
Nome #
148P The impact of chemotherapy relative dose intensity on pathological complete response and event-free survival in patients with triple-negative breast cancer treated with neoadjuvant chemotherapy 262
Correlation between weight and Recurrence Score in a cohort of HR+ve/ HER2-ve early breast cancer patients: a retrospective analysis 215
Drivers of choice and outcomes of breast-conserving surgery versus mastectomy in breast cancer patients with complete response following neoadjuvant therapy: a retrospective analysis from the EUSOMA database 197
Activation of the IGF axis in thyroid cancer: Implications for tumorigenesis and treatment 183
A novel system for semiautomatic sample processing in chronic myeloid leukaemia: Increasing throughput without impacting on molecular monitoring at time of sars-cov-2 pandemic 179
AKT Inhibitors: New Weapons in the Fight Against Breast Cancer? 172
An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal Melanoma 165
Biomarkers and prognostic factors for malignant pleural mesothelioma 162
Mutational Analysis of BRCA1 and BRCA2 Genes in Breast Cancer Patients from Eastern Sicily 161
Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice 153
Abemaciclib pharmacology and interactions in the treatment of HR+/HER2− breast cancer: a critical review 141
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery 138
Next generation sequencing in a cohort of patients with rare sarcoma histotypes: A single institution experience 131
Orbital metastasis from thyroid cancer: a case report and review of the literature 130
Opportunities and challenges of liquid biopsy in thyroid cancer 128
ENDOMETRIAL STROMAL TUMOR (SARCOMA) WITH LIMITED MIOMETRIAL INFILTRATION: A RARE CASE WITH PELVI-PERITONEAL METASTASES 128
Molecular Analysis of Luminal Androgen Receptor Reveals Activated Pathways and Potential Therapeutic Targets in Breast Cancer 127
Giant Paratesticular Liposarcoma: Molecular Characterization and Management Principles with a Review of the Literature 125
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy 123
Navigating the Nexus: HIV and Breast Cancer—A Critical Review 120
A new kid on the block: Sacituzumab govitecan for the treatment of breast cancer and other solid tumors 119
Glucose-dependent effect of insulin receptor isoforms on tamoxifen antitumor activity in estrogen receptor-positive breast cancer cells 119
In Silico Prediction of BRCA1 and BRCA2 Variants with Conflicting Clinical Interpretation in a Cohort of Breast Cancer Patients 115
Potential Therapeutic Targets for Luminal Androgen Receptor Breast Cancer: What We Know so Far 115
Medullary thyroid cancer in MEN2 pediatric/adolescent carriers of RET mutation: genotype/phenotype correlation and outcome in a retrospective series of 23 patients 114
A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine 114
The Consistency and Quality of ChatGPT Responses Compared to Clinical Guidelines for Ovarian Cancer: A Delphi Approach 112
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma 110
Abemaciclib-associated Diarrhea: An Exploratory Analysis of Real-life Data 105
Implications of antidepressants use in breast cancer: A brief review 103
Farmaci innovativi per il trattamento del carcinoma tiroideo avanzato 102
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype 102
Early Gastrointestinal Progression to Immunotherapy in Lung Cancer: A Report of Two Cases 102
Efficacy of mitomycin C plus a fluoropyrimidine in pretreated patients with metastatic colorectal cancer eligible to regorafenib: Results of a retrospective study 101
Nasopharyngeal Metastasis from Lung Adenocarcinoma: A Case Report and Literature Review 96
Real-World Analysis of Adherence to Abemaciclib and Endocrine Therapy in Women with HR+/HER2− Breast Cancer 96
Single-Cell Analysis in the Omics Era: Technologies and Applications in Cancer 94
More Than Meets the Eye: A Case of Breast Cancer Switching from Being Luminal-Androgen-Receptor-Positive to Being Hormone-Receptor-Positive 91
A systematic review of phase II trials exploring anti-PD-1/PD-L1 combinations in patients with solid tumors 89
REThinking the role of the RET oncogene in breast cancer 85
PI3K inhibition in breast cancer: Identifying and overcoming different flavors of resistance 83
Unveiling Prostate-Specific Membrane Antigen’s Potential in Breast Cancer Management 82
Delayed use of eribulin in a heavily pretreated liposarcoma patient, previously misdiagnosed as leiomyosarcoma 80
Type 2 diabetes and cancer: problems and suggestions for best patient management 77
Predictors of mastectomy in breast cancer patients with complete remission of primary tumor after neoadjuvant therapy: A retrospective study 76
Profilo Molecolare in una Coorte di Neoplasie Tiroidee Insorte nell'Area Vulcanica della Sicilia 75
Can we learn from failures? A systematic review of phase III trials in platinum-resistant ovarian cancer 74
Antibody-Drug Conjugates to Promote Immune Surveillance: Lessons Learned from Breast Cancer 74
Efficacy of A Fluoropyrimidine plus Mitomycin C in Pretreated Patients with Metastatic Colorectal Cancer Eligible for Regorafenib: A Retrospective Study 72
Ribociclib efficacy in special populations and analysis of patient reported outcomes in the MONALEESA trials 72
Everything Comes with a Price: The Toxicity Profile of DNA-Damage Response Targeting Agents 71
Entangled Connections: HIV and HPV Interplay in Cervical Cancer—A Comprehensive Review 70
Prognostic value of the interval between the last neoadjuvant chemotherapy (CT) administration and breast surgery: Preliminary data of the NeoBracer international observational study 69
The other side of the coin: dissecting molecular mechanisms behind hereditary breast cancer in search of therapeutic opportunities 69
A Multicenter Real-Life Evaluation of Safety and Effectiveness of the Antibody-Drug Conjugate Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer 56
MTClin: Integrating MammaTyper® to predict neoadjuvant therapy response in HER2+ breast cancer 56
Health-related quality of life in breast cancer patients treated with CDK4/6 inhibitors: a systematic review 55
Clinico-pathological features predicting indication to mastectomy in breast cancer patients achieving complete response after neoadjuvant therapy: A retrospective analysis of the EUSOMA database 55
Letter to the Editor: statistics and clinical perception of patients’ reported outcomes for palbociclib and abemaciclib: a sliding doors story 55
Follow-up of early breast cancer in a public health system: A 2024 AIGOM consensus project 54
A systematic review of phase I trials in patients with ovarian cancer 54
Bridging the Gap: the role of MDM2 inhibition in overcoming treatment resistance in breast cancer 53
Phase I dose-escalation study of the dual PI3K-mTORC1/2 inhibitor gedatolisib in combination with paclitaxel and carboplatin in patients with advanced solid tumors 53
Correlation between histopathological features and recurrence score according to menopausal status in HR+/HER2– breast cancer patients: a retrospective study 52
RSC4All as a machine learning nomogram to predict RSClin™ results in HR+/HER2- node-negative early breast cancer 44
Association of neoadjuvant chemotherapy dose intensity with pathological complete response and event-free survival in HER2-negative early breast cancer 36
Warming-up the immune cell engagers (ICEs) era in breast cancer: state of the art and future directions 35
Reply to: EUSOMA and NCCN should include clinical staging after neoadjuvant therapy as a quality indicator for treatment guidance 26
Unlocking the Potential of Immune Checkpoint Inhibitors in HR+/HER2− Breast Cancer: A Systematic Review 25
Radiomics in cervical and endometrial cancer 19
Totale 6.996
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.222
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.222
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202113 0 0 0 0 0 0 0 0 0 0 3 10
2021/2022118 1 14 2 2 21 2 19 3 6 5 12 31
2022/2023429 24 23 21 50 20 60 13 83 85 7 25 18
2023/2024337 43 52 16 12 11 66 3 15 2 19 45 53
2024/20251.617 43 187 81 74 238 224 72 65 67 122 266 178
2025/20264.409 252 455 859 278 642 901 443 87 228 264 0 0
Totale 6.996